United States

Becton Dickinson and Co (BDX)

BDX on New York Consolidated

21 Aug 2019
Change (% chg)

$4.09 (+1.64%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of... (more)


Beta: 1.04
Market Cap(Mil.): $45,076.07
Shares Outstanding(Mil.): 227.57
Dividend: 0.73
Yield (%): 1.47


  BDX Industry Sector
P/E (TTM): 56.67 31.72 32.67
EPS (TTM): 3.50 -- --
ROI: 2.84 14.11 14.48
ROE: 7.36 16.67 15.78

Becton Dickinson unit settles U.S. probe over unapproved medical devices

Becton Dickinson subsidiary CareFusion has agreed to pay $3.3 million to resolve claims that it bought and sold medical devices that did not have approval by the Food and Drug Administration, the Justice Department said on Monday.

May 13 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates